
Venture capital · Early stage
Abingworth LLP
London-headquartered life-science investor with US offices that finances biotech and biopharma companies through venture, later-stage and clinical co-development strategies.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Abingworth LLP right for your round?
Key stats
Fund cycle Public record
No fund vehicles on the public registers we read.
Latest investments
Rounds Abingworth LLP joined, from press and the firm’s own posts.
Every round Abingworth LLP joined
Round sizes, Abingworth LLP’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Abingworth LLP
Events where Abingworth LLP’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Abingworth LLP is based in London, United Kingdom. It also has offices in New York and San Francisco.
Stages: Seed, Early stage. Sectors: Life sciences, Biotech. From the firm’s own website.
Backs therapeutic companies aiming for materially better patient outcomes rather than incremental gains. Pairs capital with decades of sector experience, helping with hiring, board building, drug target choice, development planning and legal questions. Strategies span early venture, later-stage public and private deals, and co-development with pharma partners. From the firm’s own website.
$15M to $30M per investment, according to the firm’s own website.
Know before Abingworth LLP’s next round is announced.
PRO tracks Abingworth LLP’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.